Cold agglutinin disease (CAD) is marked by the destruction of red blood cells, cells essential to transporting oxygen to tissues. Their loss can lead to symptoms that include joint pain, fatigue, and cardiac issues. Your doctor may recommend a blood transfusion to help ease these symptoms. Here are answers to some frequently…
FAQs
Cold agglutinin disease (CAD) is a rare disorder in which the immune system produces autoantibodies that attack the body’s own red blood cells when exposed to cold temperatures. Plasmapheresis can provide temporary relief of symptoms by removing autoantibodies from the blood. Here Following are a few frequently asked questions…
A leading treatment for cold agglutinin disease (CAD) is rituximab. Following  are answers to some questions you might have before you decide to start treatment. How does rituximab work? CAD is caused by immune cells in the body called B-cells producing antibodies that bind to red…
A diagnosis of cold agglutinin disease (CAD) can be challenging for patients and their families. As a rare disease, it can be difficult to find information about CAD or its treatments. To help, below are answers to some frequently asked questions about CAD. What is CAD? CAD is a…
Recent Posts
- Issues pile up when I neglect the management of both CAD and my yard
- Enjaymo, warmth protect CAD patient during surgery: Case report
- After 50 years, my husband and I have ‘only just begun’
- Why I said no to yet another CAD blood test
- Enjaymo brings lasting gains for CAD patient misdiagnosed with cancer
- Myeloid leukemia turns up as hidden cause of CAD: Case study
- The life lessons I learned from frigid Friday night football games
- CAD study highlights need for more sensitive bone marrow testing
- Five things I do to have a positive patient experience
- Real-world data show Enjaymo reduces blood cell loss in CAD